Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MPV17L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GATM-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CHRNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRAXIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR133A1HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF195 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCC12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLJ37035 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLP1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on